| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1080/00365521.2017.1292365 |
| P698 | PubMed publication ID | 28276833 |
| P2093 | author name string | Haichuan Wang | |
| Jiwei Huang | |||
| Mingheng Liao | |||
| Zexin Zhu | |||
| P2860 | cites work | Search strategies to identify observational studies in MEDLINE and EMBASE | Q24202291 |
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis | Q26798872 | ||
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Hepatocellular carcinoma | Q29616359 | ||
| Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial | Q33871980 | ||
| Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. | Q34581507 | ||
| Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. | Q34714683 | ||
| Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma | Q35130843 | ||
| Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma | Q35786098 | ||
| Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study | Q36065568 | ||
| Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma | Q36759801 | ||
| The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus | Q37058807 | ||
| Hepatocellular carcinoma: A global view. | Q37589349 | ||
| Hepatocellular carcinoma: current management and perspectives for the future | Q37832102 | ||
| Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses | Q38206111 | ||
| Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. | Q38706131 | ||
| Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma | Q39420849 | ||
| Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis. | Q40347323 | ||
| Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study | Q42209550 | ||
| Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. | Q51731357 | ||
| Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection. | Q53108786 | ||
| Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis--a randomized study. | Q53592083 | ||
| P433 | issue | 6-7 | |
| P921 | main subject | meta-analysis | Q815382 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 624-634 | |
| P577 | publication date | 2017-02-22 | |
| P1433 | published in | Scandinavian Journal of Gastroenterology | Q7429960 |
| P1476 | title | Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis | |
| P478 | volume | 52 |
| Q64272871 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q91599660 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q97678288 | Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study |
| Q64055862 | Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction |
| Q92484964 | Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma |
| Q64228088 | Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis |
| Q93379577 | Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center |
| Q47101417 | Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict microvascular invasion in patients with hepatocellular carcinoma |
| Q64063161 | SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis |
| Q90522789 | Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion |
Search more.